Jamas

P.G. Sliields tuid N.B. Hanes Moleeular Epidemiology and the Geneties of EnvironmenttU Caneer, JAMA, 681-87,1991. [Pg.421]

Writing Group for the Women s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women s Health Initiative randomized controlled trial. JAMA 288 321-333... [Pg.393]

Dorus W, Ostrow DG, Anton R, et al Lithium treatment of depressed and nondepressed alcoholics. JAMA 262 1646—1632, 1989... [Pg.44]

Regier DA, Farmer ME, Rae DS, et al Comorhidity of mental disorders with alcohol and other drug abuse results from the Epidemiologic Catchment Area (EGA) Smdy. JAMA 264 2511-2518, 1990... [Pg.52]

Brewer C, Maksoud NA Opiate detoxification under anesthesia. JAMA 278 1318-1319, 1997... [Pg.97]

Cushman P, Dole VP Detoxification of rehabilitated methadone-maintained patients. JAMA 226 747-752, 1973... [Pg.98]

Dole VP Implications of methadone maintenance for theories of narcotic addiction. JAMA 260 3025-3029, 1988... [Pg.99]

Dole VP, Nyswander MN A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193 646-630, 1963... [Pg.99]

Herrington RE, BenzerDG, Jacobson GR, etal Treating substance use disorders among physicians. JAMA 247 2253-2237, 1982... [Pg.100]

Menk EJ, Baumgarten RK, Kingsley CP, et al Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA 263 3060-3062, 1990... [Pg.104]

Nestler EJ, Hyman SE, Malenka RC Molecular Neuropharmacology A Foundation for Clinical Neuroscience. New York, McGraw Hill, 2001 Novick DM, Pascarelli EE, Joseph H, et al Methadone maintenance patients in general medical practice a preliminary report. JAMA 259 3299—3302, 1988 Nunes EV, Quitkin EM, Donovan SJ, et al. Imipramine treatment of opiate-dependent patients with depressive disorders a placebo-controlled trial. Arch Gen Psychiatry 55 153-160, 1998... [Pg.105]

Rabinowitz J, Cohen H, Kotler M Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling. Psychiatr Serv 49 831—833, 1998 Reed PA, Schnoll SH Abuse of pentazocine-naloxone combination. JAMA 256 2562— 2564, 1986... [Pg.106]

Seecof R, Tennant FS Subjective perceptions to the intravenous rush of heroin and cocaine in opioid addicts. Am J Drug Alcohol Abuse 12 79—87, 1987 Sees KL, Delucci KL, Masson C, et al Methadone maintenance vs. 180-day psycho-socially enriched detoxification for treatment of opioid dependence a randomized controlled trial. JAMA 283 1303-1310, 2000 Sells SB Treatment effectiveness, in Handbook on Drug Abuse. Edited by Dupont RE, Goldstein A, O Donnell J. Washington, DC, U.S. Government Printing Office, 1979, pp 105-118... [Pg.107]

Stimmel B, Goldberg], RotkopfE, et al Ability to remain abstinent after methadone detoxification a six year study. JAMA 237 1216—1220, 1977... [Pg.108]

Umbricht A, Hoover DR, Tucker MJ, et al Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend 69 263-272, 2003 Villagomez RE, Meyer TJ, Lin MM, et al Post-traumatic stress disorder among inner city methadone maintenance patients. Subst Abuse Treat 12 253—257, 1995 Mining E, Kosten TR, Kleber H Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 83 567-575, 1988 Washton AM, Pottash AC, Gold MS Naltrexone in addicted business executives and physicians. J Clin Psychiatry 45 39 1, 1984 Wesson DR Revival of medical maintenance in the treatment of heroin dependence (editorial). JAMA 259 3314-3315, 1988... [Pg.109]

Mellinger GD, Balter MB, Uhlenhuth EH Prevalence and correlates of the long-term regular use of anxiolytics. JAMA 231 375-379, 1984... [Pg.157]

Rickels K, Case WG, Downing RW, et al Long-term diazepam therapy and clinical outcome. JAMA 230 767-771, 1983... [Pg.159]

Hughes JR, Goldstein MG, Hurt RD, et al Recent advances in the pharmacotherapy ofsmoking. JAMA 281 72-76, 1999... [Pg.178]

Parker LA, Gillies T THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav Neurosci 109 71-78, 1995 Pope HG, Yurgelun-Todd D The residual cognitive effects of heavy marijuana use in college students. JAMA 275 521-327, 1996 Robson P Therapeutic aspects of cannabis and cannabinoids. BrJ Psychiatry 178 107-115, 2001... [Pg.180]

Griffith JD, Oates JA, Cavanaugh JH Paranoid episodes induced by drugs. JAMA 205 39-46, 1968... [Pg.204]

Bowen JS, Davis GB, Kearney TE, et al Diffuse vascular spasm associated with 4-bromo-2,5-dimethoxyamphetamine ingestion. JAMA 249 1477-1479, 1983 Brands B, Sproule B, Marshman J Drugs and Drug Abuse, 3rd Edition. Toronto, Ontario, Addiction Research Foundation, Fondation de la recherche sur la toxi-comanie, 2001... [Pg.237]

Cohen S, Ditman K Complications associated with lysergic acid diethylamide (LSD-25). JAMA 181 161-162, 1962... [Pg.238]

Ricaurte GA, McCann UD, Szabo Z, et al Toxicodynamics and long-term toxicity of the recreational drug 3,4-methylenedioxy-methamphetamine (MDMA, Ecstasy ). Toxicol Lett 112-113 143-146, 2000 Robinson TN, Killen JD, Taylor CB, et al Perspectives on adolescent substance use a defined population study. JAMA 258 2072-2076, 1987 Rubinstein JS Abuse of antiparkinson drugs feigning of extrapyramidal symptoms to obtain trihexyphenidyl. JAMA 239 2365, 1978 Rumack BH (ed) LSD, in Poisindex, Vol 54. Denver, CO, Micromedex, 1987 Rusyniak DE, Banks ML, Mills EM, et al Dantrolene use in 3,4-methylenedioxymethamphetamine ( ecstasy )-medicated hyperthermia (letter). Anesthesiology 10 263, 2004... [Pg.240]

Verebey K, Alrazi J, Jaffe JH The complications of ecstasy (MDMA) (letter). JAMA... [Pg.241]

Centers for Disease Control and Prevention Gamma hydroxy butyrate use—New York and Texas, 1995-96. JAMA 277 1511, 1997 Centers for Disease Control and Prevention Adverse events associated with ingestion of gamma-butyrolactone—Minnesota, New Mexico, and Texas, 1998-1999. MMRW Morb Mortal Wkly Rep 48 137-140, 1999 Chatlos JC Recent trends and a developmental approach to substance abuse in adolescents. Child Adolesc Psychiatr Clin N Am 5 1-27, 1996... [Pg.261]

Reich DL, Silvay G Ketamine an update on the first twenty-five years of clinical experience. Can J Anaesth 36 186—197, 1989 Ricaurte GA, Forno LS, Wilson MA, et al (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260 51-55, 1988... [Pg.265]

Fiore MC, Smith SS, Jorenby DE, et al The effectiveness of the nicotine patch for smoking cessation. JAMA 271 1940-1947, 1994 Fiore MC, Bailey WC, Cohen SJ, et al Smoking Cessation. Clinical Practice Guideline No 18 (ACHPRPublNo 96-0692). Rockville, MD, U.S. Department of Health and Human Services, 1996... [Pg.335]

Hurt RD, Offord KP, Croghan IT, et al Mortality following inpatient addictions treatment role of tobacco use in a community-based cohort. JAMA 275 1097—1103, 1996... [Pg.336]

Johnson A, Jasinski DR, Galloway GP, et al Ritanserin in the treatment of alcohol dependence a multi-center clinical trial. Psychopharmacol 128 206—215, 1996 Johnson BA, Roache JD, Javors MA, et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients a randomized controlled trial. JAMA 284 963-971, 2000... [Pg.359]

Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI (2006) Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295 891-894... [Pg.22]

Hagiwara T, Kijima-Suda I, Ido T, Ohrui H, Tomita K (1994) Inhibition of bacterial and viral sialidases by 3-fluoro-V-acetyIneuraminic acid, Carbohydr Res 263 167-172 Haskell TH, Peterson FE, Watson D, Plessas NR, Culbertson T (1970) Neuraminidase inhibition and viral chemotherapy, J Med Chem 13 697-704 Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors, JAMA 297 1435-1442 Hay AJ (1992) The action of adamantanamines against influenza A viruses inhibition of the M2 ion channel protein, Semin Virol 3 21-30... [Pg.148]

Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL (2001) Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1994-1997. JAMA 285 1308-1315 Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, Lieber M, Martin SL, Bushman FD (2001) Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J 20 3272-3281... [Pg.173]

Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K (2003) Short interfering RNA-directed inhibition of hepatitis B vims replication. EEBS Lett 543 51-54 He ML, Zheng B, Peng Y, Peiris IS, Poon LL, Yuen KY, Lin MC, Kung HP, Guan Y (2003) Inhibition of SARS-associated coronavims infection and replication by RNA interference. JAMA 290 2665-2666... [Pg.259]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...